{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:44:58Z","timestamp":1777128298258,"version":"3.51.4"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"Background<\/jats:title>Type III Bartter syndrome (BS) is an autosomal recessive disease caused by mutations in the CLCNKB<\/jats:italic> (chloride voltage-gated channel Kb) gene that encodes CLC-Kb. CLC-Kb is mainly located in the thick ascending limb of Henle's loop and regulates chloride ef\ufb02ux from tubular epithelial cells to the interstitium. Type III BS is characterized by metabolic alkalosis, renal salt wasting, hyperreninemia, and hyperaldosteronism with normal blood pressure.<\/jats:p><\/jats:sec>Case presentation<\/jats:title>We reported the case of a 3-day-old girl whose initial symptom we diagnosed as jaundice, but we accidentally found metabolic alkalosis. She showed recurrent metabolic alkalosis, hypokalemia, and hypochloremia and also had hyperreninemia and hyperaldosteronism with normal blood pressure. Both oral potassium supplements and potassium infusion therapy were unable to entirely restore the electrolyte imbalance. She was suspected of Bartter syndrome and genetic tests were performed on her and her parents. Next-generation sequencing identified CLCNKB<\/jats:italic> gene mutation including heterozygous mutation c.1257delC (p.M421Cfs*58) and a low-level mutation c.595G\u2009&gt;\u2009T (p.E199*); both mutations were also verified in the parents.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>We reported the case of a classic Bartter syndrome in a newborn with a heterozygous frameshift mutation and a mosaic non-sense mutation in the CLCNKB<\/jats:italic> gene.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1034923","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T04:43:57Z","timestamp":1681706637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["A mosaic mutation in the CLCNKB gene causing Bartter syndrome: A case report"],"prefix":"10.3389","volume":"11","author":[{"given":"Lan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojiao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/IJNRD.S155397","article-title":"Bartter syndrome: causes, diagnosis, and treatment","volume":"11","author":"Cunha","year":"2018","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pcl.2018.08.010","article-title":"Bartter syndrome and Gitelman syndrome","volume":"66","author":"Fulchiero","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1507\/endocrj.EJ14-0125","article-title":"Bartter syndrome type 3 in an elderly complicated with adrenocorticotropin-deficiency","volume":"61","author":"Tamagawa","year":"2014","journal-title":"Endocr J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"F1324","DOI":"10.1152\/ajprenal.00004.2015","article-title":"ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3","volume":"308","author":"Andrini","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"24527","DOI":"10.1074\/jbc.M001987200","article-title":"Functional and structural analysis of ClC-K chloride channels involved in renal disease","volume":"275","author":"Waldegger","year":"2000","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0959-440X(02)00358-5","article-title":"CLC chloride channels: correlating structure with function","volume":"12","author":"Estevez","year":"2002","journal-title":"Curr Opin Struct Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1152\/physrev.00029.2001","article-title":"Molecular structure and physiological function of chloride channels","volume":"82","author":"Jentsch","year":"2002","journal-title":"Physiol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0009-9120(76)80067-7","article-title":"Elevation of serum creatine kinase in severe hypokalemic hyperaldosteronism","volume":"9","author":"Crawhall","year":"1976","journal-title":"Clin Biochem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-3-22","article-title":"Gitelman syndrome","volume":"3","author":"Knoers","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12020-019-02156-9","article-title":"Thirteen novel CLCNKB variants and genotype\/phenotype association study in 42 Chinese patients with Bartter syndrome type 3","volume":"68","author":"Han","year":"2020","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3346\/jkms.2016.31.1.47","article-title":"Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like syndrome","volume":"31","author":"Lee","year":"2016","journal-title":"J Korean Med Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/jmg.25.5.358","article-title":"Trisomy 3 mosaicism in a patient with Bartter syndrome","volume":"25","author":"De Keyser","year":"1988","journal-title":"J Med Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tig.2015.03.013","article-title":"Somatic mosaicism: implications for disease and transmission genetics","volume":"31","author":"Campbell","year":"2015","journal-title":"Trends Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2174\/0929867324666170718101946","article-title":"NGS technologies as a turning point in rare disease research, diagnosis and treatment","volume":"25","author":"Fernandez-Marmiesse","year":"2018","journal-title":"Curr Med Chem"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1034923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T04:44:00Z","timestamp":1681706640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1034923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":15,"alternative-id":["10.3389\/fped.2023.1034923"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1034923","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1034923"}}